ALIGOS Therapeutics

About
Science
- Pipeline
- Posters & Presentations
Patients
News & Media
- Press Releases
- Presentations & Events
Investors
Careers

About
Science
- Pipeline
- Posters & Presentations
Patients
News & Media
- Press Releases
- Presentations & Events
Investors
Careers

Capsid Assembly Modulator ALG-001075 Prevents CCCDNA Formation and HBV DNA Integration in Vitro

Pevifoscorvir-sodium, Publications

Capsid Assembly Modulator ALG-001075 Prevents CCCDNA Formation and HBV DNA Integration in Vitro

US OFFICE
1 Corporate Dr., 2nd Floor
South San Francisco, CA 94080

EU OFFICE
Gaston Geenslaan 1 / (Building 3)
3001 Leuven, Belgium
+32 (0)16 88 28 10

CHINA OFFICE
Unit 3212, Building A, No. 100, Zunyi Road, Changning District, Shanghai, People’s Republic of China, 200051

FOLLOW US

info@aligos.com

© Aligos Therapeutics 2026

Privacy Policy
Terms of Service
Financial Conflict of Interest Policy

MENU

About
Science
- Pipeline
- Posters & Presentations
Patients
News & Media
- Press Releases
- Presentations & Events
Investors
Careers